Be part of the knowledge.™

Universal Implications of DES

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.

Roxanna Mehran, MD

Roxanna Mehran, MD

Larry Kaskel, MD

Larry Kaskel, MD

Recommended

Details

Presenters

Overview
In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.

Roxanna Mehran, MD

Roxanna Mehran, MD

Larry Kaskel, MD

Larry Kaskel, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

Application of guidelines-recommended broad molecular profiling to patients with NSCLC

Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer

Personalizing Care Within the RCC Treatment Paradigm

Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations

Navigating Myasthenia Gravis in Adolescents and Young Adults

MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies